Answer
Orladeyo is indicated for routine prevention of recurrent hereditary angioedema attacks in adults and adolescents aged 12 years and older.
Sources for this answer
- Orladeyo 150mg capsuleBioCryst UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated
Sources checked